Cite
HARVARD Citation
Kim, M. et al. (2018). A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status. Pharmaocogenetics and genomics. 28 (1), p. . [Online].